CYP1B1 and kidney cancer: Furthermore, miR-27b-3p improves the sensitivity of liver and kidney cancer cell to anti-cancer drugs via activating p53-dependent apoptosis and reducing Cytochrome P450 Family 1 Subfamily B Member 1 (CYP1B1)-mediated drug detoxication [14].